Loading...

Stella Pharma Corporation

4888.T•JPX
Healthcare
Biotechnology
¥421.00
¥1.00(0.24%)

Stella Pharma Corporation (4888.T) Company Profile & Overview

Explore Stella Pharma Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Stella Pharma Corporation (4888.T) Company Profile & Overview

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.

SectorHealthcare
IndustryBiotechnology
CEOKoki Uehara

Contact Information

https://www.stella-pharma.co.jp
81 6 4707 1516
ORIX Kouraibashi Building, Osaka, 541-0043

Company Facts

44 Employees
IPO DateApr 22, 2021
CountryJP
Actively Trading

Frequently Asked Questions

;